Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

September 20, 2024

Study Completion Date

February 18, 2025

Conditions
Premature Ovarian Failure
Interventions
BIOLOGICAL

Intra-ovarian injection of bone marrow mesenchymal stromal cells-derived extracellular vesicles

he patient is anesthetized and placed in a lithotomy position, after preparing and washing the vagina with normal saline, under transvaginal ultrasound guidance (Aloka-40000 vaginal probe, Japan) using needle puncture (Reproline medical Gmbh, Rheinbach/Germany). The injection of 2 ml of extracellular vesicles derived from MSCs (equivalent to 30 million cells) will be performed into one ovary of the patient (the accessible ovary).

Trial Locations (1)

Unknown

RECRUITING

Royan Institute, Tehran

All Listed Sponsors
lead

Royan Institute

OTHER_GOV